Hypertension and heart failure affect millions worldwide. Yet in many patients, doctors cannot fully explain why the heart ...
More than 300,000 people suffer a heart attack in Germany every year. The heart muscle is then no longer supplied with sufficient blood and oxygen, and part of the tissue dies and scars. Unlike the ...
Late-breaking presentation at MDA to feature Phase 3 HOPE-3 results supporting Deramiocel in Duchenne muscular ...
Regenerative medicines are headed for people with Parkinson’s disease or severe heart failure — but researchers are concerned about minimal clinical-trial data.
A groundbreaking study shatters the myth of permanent cardiac damage, revealing that the heart can naturally trigger cell ...
A health ministry panel has conditionally approved, for a limited time, two regenerative medical products derived from induced pluripotent stem (iPS) cells, a key milestone in the possible wider use ...
DOING any kind of exercise will benefit your health in the long-term, lowering your risk of disease and keeping you fit and limber for longer. But men who want to boost their sex drive and delay ...
Japan Approves Worlds First iPS Therapies for Parkinsons, Heart Failure Conditional approval granted for Sumitomo Pharmas ...
The earliest they are likely to become available is around summer, after drug pricing has been finalized. These products will be covered by the public health insurance system. The out-of-pocket burden ...
A health ministry expert panel has cleared the commercialization of two regenerative medicine products derived from induced ...
Drugs made with iPS, or induced pluripotent stem cells, will be used to treat patients with severe heart failure and Parkinson’s disease.
Researchers have uncovered a new way to attack lymphoma by targeting a non-catalytic region of a key regulatory enzyme, rather than its traditional active site. Researchers at VCU Massey Comprehensive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results